Biotech Values

[DewDiligence]

MNT – 700 patients enrolled in less than 2 months—
not bad. Note that this is not the same phase-3 trial as
the one mentioned in #msg-20954009.

http://biz.yahoo.com/bw/080129/20080129006415.html?.v=1

>>
Mentor Announces Completion of Subject Enrollment in Pivotal Trial for Botulinum Toxin Type A

Tuesday January 29, 4:30 pm ET

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Mentor Corporation (NYSE: MNT ), a leading supplier of medical products for the global aesthetic market, announced today that subject enrollment and initial dosing in its pivotal Phase IIIb study of its investigational botulinum toxin type A for the reduction of glabellar rhytides (frown lines) by intramuscular injection has been completed. Enrollment in the IIIb trial, which consisted of 700 subjects, began in late November and was completed in mid January.

Joshua H. Levine, President and Chief Executive Officer of Mentor Corporation, commented, “We are very excited about the rapid completion of subject enrollment in Phase IIIb of our botulinum toxin clinical trial. Our investigators observed strong subject interest in the study drug and this leads us to believe that the market is primed for new products focused on the large and rapidly growing cosmetic application.”

“Based on my participation in these clinical studies, I am very impressed with the results I am seeing with this new formulation of botulinum toxin,” said Dr. Joel Schlessinger, a board certified physician in dermatology and cosmetic surgery and President emeritus of American Society of Dermatology and current President of Aesthetic Surgery. He further stated “there is a significant amount of interest and excitement about new products being developed for the cosmetic indication focused on the reduction of glabellar rhytides (frown lines).”

About Mentor Corporation

Founded in 1969, Mentor Corporation is a leading supplier of medical products for the global aesthetic market. The Company develops, manufactures and markets innovative, science-based products for surgical and non-surgical medical procedures that allow patients to retain a more youthful appearance and improve personal well-being. The Company's website is www.mentorcorp.com.
<<